GH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early Results
Clinical trial NCT05010694 · UNKNOWN
Trial details
- NCT number
- NCT05010694
- Sponsor
- Suzhou Genhouse Bio Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2023-03-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.